Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Niva Bupa Health Insurance Company Ltd has witnessed a marked shift in its valuation parameters, moving from a risky to a very expensive territory. Despite recent positive price momentum, the company’s elevated price-to-earnings and price-to-book ratios relative to peers and historical averages raise questions about its price attractiveness for investors seeking value in the insurance sector.

Niva Bupa Health Insurance Company Ltd has emerged as one of the most actively traded stocks on 11 May 2026, registering a remarkable surge in volume alongside robust price appreciation. The stock outperformed its sector and broader market indices, signalling renewed investor interest and potential accumulation in this small-cap insurance player.

While the Sensex declined by 1.06% on 11 May 2026, Niva Bupa Health Insurance Company Ltd surged 8.33%, marking a striking 10.19 percentage-point outperformance over its sector. The stock’s intraday high of Rs 89.47 and a robust 25.26% intraday volatility underscore a session dominated by stock-specific strength rather than broader market momentum.

Niva Bupa Health Insurance Company Ltd. posted a dramatic quarterly turnaround in Q4 FY26, swinging to a net profit of ₹345.13 crores from a loss of ₹87.64 crores in the preceding quarter, marking a remarkable reversal for the health insurance specialist. The stock, trading at ₹81.27 as of May 08, 2026, has responded positively to the results, gaining 1.52% in the latest session and currently commanding a market capitalisation of ₹14,745.00 crores in the small-cap segment.

Niva Bupa Health Insurance Company Ltd has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on weekly charts. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and volume-based metrics. This analysis delves into the evolving price momentum and technical parameters shaping investor sentiment as the stock navigates a challenging insurance sector backdrop.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 30 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 22 April 2026, providing investors with the latest perspective on the company’s performance and valuation.

Niva Bupa Health Insurance Company Ltd has exhibited a notable shift in its technical momentum, transitioning from a mildly bearish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for the small-cap insurer amid recent price gains and sector dynamics.

Niva Bupa Health Insurance Company Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent 3.22% gain in daily price, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum tools. This analysis delves into the evolving technical landscape of this small-cap insurance stock and its implications for investors.

Niva Bupa Health Insurance Company Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent 2.81% gain in daily price, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain inconclusive or bearish. This analysis delves into the latest technical parameters, price momentum, and comparative returns to provide a comprehensive view for investors.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Niva Bupa Health Insurance Company Ltd has seen its investment rating downgraded from Strong Sell to Sell as of 30 March 2026, reflecting a complex interplay of financial performance, valuation concerns, and evolving technical indicators. Despite some long-term growth strengths, recent quarterly results and technical trends have prompted a cautious stance from analysts.

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a firmly bearish stance to a mildly bearish trend. Despite this slight improvement, the stock remains under pressure with a strong sell rating and a market cap classified as small-cap. This article analyses the recent technical indicators, price movements, and relative performance against the broader market to provide a comprehensive view for investors.

Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 March 2026, providing investors with the latest perspective on the company’s position.

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 2 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Niva Bupa Health Insurance Company Ltd has declined to a fresh 52-week low of Rs 67.97, reflecting ongoing pressures within the insurance sector and broader market weakness. The stock’s recent performance underscores a challenging period marked by subdued quarterly results and a cautious market environment.